ClinicalTrials.Veeva

Menu

Clinical Evaluation of Ultrasonic Hydration Monitor for Infants (IHM-01)

A

Artann Laboratories

Status

Completed

Conditions

Dehydration
Diarrhea

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT01482208
IHM-01
Gates Foundation (Other Identifier)

Details and patient eligibility

About

Study will verify ability of infant Hydration Monitor (IHM) to assess changes of hydration status in newborns and infants by means of ultrasound velocity measurements through muscle tissues. Changes of tissue hydration will be followed during first days of life in newborns and in acute diarrhea in small children during re-hydration therapy. Weighting and clinical dehydration symptoms will be used as controls.

Enrollment

42 patients

Sex

All

Ages

1 day to 3 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Newborns from 1 to 7 days old,
  • Health infants from 1 month to 3 years old,
  • Any ethnicity,
  • Male or female,
  • Infants with diarrhea,
  • Acute gastroenteritis,
  • Diarrhea and/or vomiting,
  • Suspected dehydration

Exclusion criteria

  • Congenital heart disease,
  • Renal failure,
  • Chronic liver disease,
  • Chronic lung disease,
  • Inflammatory bowel disease,
  • Immune deficiency,
  • Severe malnutrition,
  • Any external damage to skin of leg,
  • Infants and Children whose parents refuse permission to be included

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems